Tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate
C33H37FN2O4 — CID 156879021
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate
Tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate (PubChem CID 156879021) has the molecular formula C33H37FN2O4 and a molecular weight of 544.67 g/mol. Its IUPAC name is tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate.
Molecular Properties
| Compound Name | Tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate |
|---|---|
| PubChem CID | 156879021 |
| Molecular Formula | C33H37FN2O4 |
| Molecular Weight | 544.67 g/mol |
| Exact Mass | 544.27 |
| IUPAC Name | tert-butyl 4-[1-(4-fluorophenyl)-4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-propan-2-ylindol-3-yl]benzoate |
| SMILES | CC(C)c1c(-c2ccc(C(=O)OC(C)(C)C)cc2)c2c(NC(=O)OC(C)(C)C)cccc2n1-c1ccc(F)cc1 |
| InChI | InChI=1S/C33H37FN2O4/c1-20(2)29-27(21-12-14-22(15-13-21)30(37)39-32(3,4)5)28-25(35-31(38)40-33(6,7)8)10-9-11-26(28)36(29)24-18-16-23(34)17-19-24/h9-20H,1-8H3,(H,35,38) |
| InChIKey | ORLFCXURGJRHTP-UHFFFAOYSA-N |
| XLogP | 8.86 |
| TPSA | 69.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 544.67 |
| LogP ≤ 5 | 8.86 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156879021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.